Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR2 | P50052 | 11/20 | 0.74 |
| ▸ | AGTR1 | P30556 | 3/20 | 0.74 |
| ▸ | REN | P00797 | 2/20 | 0.69 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.59 |
| ▸ | NPY1R | P25929 | 1/20 | 0.58 |
| ▸ | NPY2R | P49146 | 1/20 | 0.58 |
| ▸ | NPY4R | P50391 | 1/20 | 0.58 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Angiotensin Amide SCHEMBL8155919 | 1.00 | AGTR2 (0.74) | AGTR2AGTR1RENLNPEPNPY1R | |
| Angiotensin Amide SCHEMBL7337886 | 0.99 | AGTR2 (0.73) | AGTR2AGTR1RENLNPEPNPY1R | |
| Angiotensin Amide SCHEMBL9433448 | 0.99 | AGTR2 (0.73) | AGTR2AGTR1RENLNPEPNPY1R | |
| Angiotensin Amide SCHEMBL2197068 | 0.99 | AGTR2 (0.73) | AGTR2AGTR1RENLNPEPNPY1R | |
| Angiotensin Amide SCHEMBL10495835 | 0.98 | AGTR2 (0.72) | AGTR2AGTR1RENLNPEPNPY1R | |
| Angiotensin Amide SCHEMBL23015107 | 0.98 | AGTR2 (0.71) | AGTR2AGTR1RENLNPEPNPY1R | |
| Angiotensin Amide SCHEMBL3850850 | 0.98 | AGTR2 (0.71) | AGTR2AGTR1RENLNPEPNPY1R | |
| Angiotensin Amide SCHEMBL5722115 | 0.97 | AGTR2 (0.75) | AGTR2AGTR1RENNPY1RNPY2R | |
| Angiotensin Ii SCHEMBL513519 | 0.95 | AGTR2 (0.82) | AGTR2AGTR1RENLNPEPNPY1R | |
| Angiotensin Amide SCHEMBL9023554 | 0.95 | AGTR2 (0.68) | AGTR2AGTR1RENNPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 129756 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144825-A1 | METHODS OF TREATING EYE DISEASES USING OPTIC NERVE LAMINA REGION NEURAL PROGENITOR CELL-DERIVED SECRETED EXTRACELLULAR VESICLES AND FREE PROTEINS | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2026-05-28 | — | — | US | claimed |
| EP-4747247-A1 | NOVEL FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | Apogee Pharmaceuticals, Inc. (CA) | 2026-05-27 | — | — | EP | claimed |
| CN-122091153-A | Primary aldosterone prediction model for hyperemia subtype | — | 2026-05-26 | — | — | CN | claimed |
| US-12637461-B2 | Compounds for the activation of AMPK | PFIZER INC. (US) | 2026-05-26 | — | — | US | claimed |
| EP-4041275-B1 | TREATMENT AND PREVENTION OF NEPHROTOXIN-INDUCED KIDNEY INJURIES | FARSIGHT MEDICAL TECH SHANGHAI CO LTD (CN) | 2026-05-20 | — | — | EP | claimed |
| US-12630822-B2 | Treatment of heart failure in human subjects | NOVO NORDISK A/S (DK) | 2026-05-19 | — | — | US | claimed |
| EP-4739283-A1 | PEPTIDE STEREOCOMPLEXATION WITH BIODEGRADABLE STEREOREGULAR POLYESTERS IN WATER AND HYDROGEL FORMS THEREOF | Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. (IL) | 2026-05-13 | — | — | EP | claimed |
| EP-4734966-A2 | SYSTEM AND METHOD FOR SUSTAINED RELEASE OF AGENTS IN THE BLADDER | Watershed Medical, Inc. (US) | 2026-05-06 | — | — | EP | claimed |
| EP-4125858-B1 | NUTRITIONAL COMPOSITION COMPRISING L-CARNITINE TARTRATE FOR USE IN TREATING OR PREVENTING A CORONAVIRUS INFECTION IN A MAMMAL | LONZA GREENWOOD LLC (US) | 2026-05-06 | — | — | EP | claimed |
| WO-2026087680-A1 | TREATMENT FOR CARDIOVASCULAR DISEASE | SAPREME TECHNOLOGIES B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| US-4153725-A | ANGIOTENSIN CONVERTING ENZYME INHIBITORS | E. R. SQUIBB & SONS, INC. (US) | 1979-05-08 | — | — | US | claimed |
| US-4140797-A | MERCAPTOACYL AMINO ACIDS, ENZYME INHIBITORS | E. R. SQUIBB & SONS, INC. (US) | 1979-02-20 | — | — | US | claimed |
| US-4140786-A | ENZYME INHIBITORS | E. R. SQUIBB & SONS, INC. (US) | 1979-02-20 | — | — | US | claimed |
| US-4113433-A | RADIOIMMUNOASSAY OF HORMONES AND METABOLITES IN BLOOD SERUM AND PLASMA | KHARE GYANESHWAR PRASAD | 1978-09-12 | — | — | US | claimed |
| US-4112119-A | MERCAPTOACYL AMINOACIDS | E. R. SQUIBB & SONS, INC. (US) | 1978-09-05 | — | — | US | claimed |
| US-4108726-A | Sarcoidosis test | RESEARCH CORPORATION (US) | 1978-08-22 | — | — | US | claimed |
| US-4105789-A | Carboxyalkylacylamino acids | E. R. SQUIBB & SONS, INC. (US) | 1978-08-08 | — | — | US | claimed |
| US-4104029-A | CHEMILUMINESCENT LABELING | MAIER JR CHARLES L | 1978-08-01 | — | — | US | claimed |
| US-4097586-A | Immunochemical assay method | BIOLOGICAL DEVELOPMENTS, INC. (US) | 1978-06-27 | — | — | US | claimed |
| US-4053651-A | MERCAPTOACYL AMINO ACIDS, ENZYME INHIBITORS | E. R. SQUIBB & SONS, INC. (US) | 1977-10-11 | — | — | US | claimed |